Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma.

Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma.

Item
http://www.wikidata.org/entity/Q40795146
The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteinsA novel phthalimide derivative, TC11, has preclinical effects on high-risk myeloma cells and osteoclastsRecent advances in antimultiple myeloma drug development.Ubiquitylation of nuclear receptors: new linkages and therapeutic implications.New approaches to management of multiple myeloma.Effect of pomalidomide on relapsed/refractory multiple myeloma: a systematic review and meta-analysis.Pomalidomide in the treatment of multiple myeloma: design, development and place in therapy.Human cytochrome P450 oxidation of 5-hydroxythalidomide and pomalidomide, an amino analogue of thalidomide.Inhibition of endothelial Slit2/Robo1 signaling by thalidomide restrains angiogenesis by blocking the PI3K/Akt pathway.
P2860

Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma.

Item
http://www.wikidata.org/entity/Q40795146
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma.
@en
type
label
Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma.
@en
prefLabel
Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
Pomalidomide: a novel drug to treat relapsed and refractory multiple myeloma.
@en
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P5875
P698
P932